Observing..., page-11

CB,

Me again. I forgot to respond to your cap raising comment.

Clinical trials are expensive and neu are/were running four. But look at there cash burn. They use up so very little and gain much from grants and the US army.

I had been concerned when I heard that they planned to run 4 trials at once, but a year later they have spent only a quarter of their cash. At this rate they could fund some for nnz2591 as well!

I don't think there will be any phase 3's, as they will get fast tracked for all of their successful indications. But if one is needed the cashed up US groups and US army will fund them anyway.

All in my opinion,

Cheers